Evidence map›Paper›PMID 20688780›Full record

ArticleGenome research2010

Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.

Jonathan Nissenbaum, Marshall Devor, Ze'ev Seltzer, Mathias Gebauer, Martin Michaelis, Michael Tal, Ruslan Dorfman, Merav Abitbul-Yarkoni, Yan Lu, Tina Elahipanah and 9 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Genome research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04798573 (Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain), which is not on this map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04798573 active not recruitingnot on this mapstarted 2012, after this paper: background citation

Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain: A Multicenter Prospective Study

TypeobservationalSponsorUniversity Health Network, TorontoRan2012 to 2025Enrolled10,000ConditionsChronic Pain, Surgery
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Personalized Medicine in Cancer Pain Management.Journal of personalized medicine · 2023
    Review
  8. A compendium of validated pain genes.WIREs mechanisms of disease · 2022
    Review
  9. Article
  10. Article
  11. Ion channel long non-coding RNAs in neuropathic pain.Pflugers Archiv : European journal of physiology · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 5 countries.

Jonathan NissenbaumDepartment of Genetics, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Marshall Devor
Ze'ev Seltzer
Mathias Gebauer
Martin Michaelis
Michael Tal
Ruslan Dorfman
Merav Abitbul-Yarkoni
Yan Lu
Tina Elahipanah
Sonia delCanho
Anne Minert
Kaj Fried
Anna-Karin Persson
Hagai Shpigler
Erez Shabo
Benjamin Yakir
Anne Pisanté
Ariel Darvasi
Hebrew University of Jerusalem · ILUniversity of Toronto · CAKarolinska Institutet · SESanofi (France) · FRHospital for Sick Children · CAMount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic neuropathic pain is affected by specifics of the precipitating neural pathology, psychosocial factors, and by genetic predisposition. Little is known about the identity of predisposing genes. Using an integrative approach, we discovered that CACNG2 significantly affects susceptibility to chronic pain following nerve injury. CACNG2 encodes for stargazin, a protein intimately involved in the trafficking of glutamatergic AMPA receptors. The protein might also be a Ca(2+) channel subunit. CACNG2 has previously been implicated in epilepsy. Initially, using two fine-mapping strategies in a mouse model (recombinant progeny testing [RPT] and recombinant inbred segregation test [RIST]), we mapped a pain-related quantitative trait locus (QTL) (Pain1) into a 4.2-Mb interval on chromosome 15. This interval includes 155 genes. Subsequently, bioinformatics and whole-genome microarray expression analysis were used to narrow the list of candidates and ultimately to pinpoint Cacng2 as a likely candidate. Analysis of stargazer mice, a Cacng2 hypomorphic mutant, provided electrophysiological and behavioral evidence for the gene's functional role in pain processing. Finally, we showed that human CACNG2 polymorphisms are associated with chronic pain in a cohort of cancer patients who underwent breast surgery. Our findings provide novel information on the genetic basis of neuropathic pain and new insights into pain physiology that may ultimately enable better treatments.

Indexed as

AnimalsCalcium ChannelsCohort StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMiceMice, Inbred StrainsNeuralgiaPhenotypePolymorphism, GeneticQuantitative Trait LociSpinal NervesCACNG2 protein, humanCacng2 protein, mouseCalcium Channels

Identifiers

PMID20688780
PMCPMC2928496
OpenAlexW2104335028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.